NASDAQ | ETF
The fund normally invests at least 80% of assets in securities of disruptive medicine companies.
Fidelity's disruptive strategies seek to identify innovative developments that could signal new directions for delivering products and services to customers.
Generally, these companies have or are developing new or unconventional ways of doing business that could disrupt and displace incumbents over time.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| BSX | Boston Scientific Corp | Healthcare | Medical Devices | 5.48% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 3.86% |
| VEEV | Veeva Systems Inc Class A | Healthcare | Health Information Services | 3.68% |
| PODD | Insulet Corporation | Healthcare | Medical Devices | 3.50% |
| DHR | Danaher Corporation | Healthcare | Diagnostics & Research | 3.46% |
| WAY | Waystar Holding Corp. Common Stock | Healthcare | Health Information Services | 3.27% |
| ARGX | argenx NV ADR | Healthcare | Biotechnology | 3.17% |
| ISRG | Intuitive Surgical Inc | Healthcare | Medical Instruments & Supplies | 3.15% |
| EXAS | EXACT Sciences Corporation | Healthcare | Diagnostics & Research | 3.13% |
| PEN | Penumbra Inc | Healthcare | Medical Devices | 3.11% |
| LEGN | Legend Biotech Corp | Healthcare | Biotechnology | 2.86% |
| UNH | UnitedHealth Group Incorporated | Healthcare | Healthcare Plans | 2.69% |
| UCB | UCB SA | Healthcare | Biotechnology | 2.69% |
| SYK | Stryker Corporation | Healthcare | Medical Devices | 2.50% |
| EW | Edwards Lifesciences Corp | Healthcare | Medical Devices | 2.44% |
| MASI | Masimo Corporation | Healthcare | Medical Devices | 2.39% |
| DIM | Sartorius Stedim Biotech SA | Healthcare | Medical Instruments & Supplies | 2.27% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 1.95% |
| RPRX | Royalty Pharma Plc | Healthcare | Biotechnology | 1.88% |
| DXCM | DexCom Inc | Healthcare | Medical Devices | 1.88% |